T
TubeFolio
Back to Dashboard

Affirm Stock: Follow Now and Buy Later or Buy Right Now? | AFRM Stock Analysis

Parkev Tatevosian, CFAAug 28, 2026

Summary

Parkev analyzes Affirm's position in the "Buy Now, Pay Later" (BNPL) sector, highlighting its commitment to consumer trust through the elimination of late fees and hidden charges. This approach necessitates superior underwriting standards since the company cannot rely on fees to offset losses. Parkev points out that Affirm has achieved significant revenue growth, reaching nearly $4 billion in trailing 12-month revenue, and has successfully pivoted toward operating profitability, which now stands at 21%.

The analysis further explores the market environment, noting that Affirm benefits from industry-wide tailwinds as both merchants and consumers find value in deferred payment options. Parkev explains that Affirm's strategy of selling loans to third-party lenders remains effective, as these lenders seek the double-digit returns offered by BNPL assets compared to lower-yielding government bonds. Finally, Parkev examines valuation metrics, noting that Affirm trades at a reasonable forward P/E ratio and appears undervalued based on a discounted cash flow model.

AFRM: Parkev reiterates a buy rating for Affirm, citing a calculated fair value of $88 per share against a current price of $78. He emphasizes the company's 38% compounded annual growth rate and its improving operating margins as key drivers for long-term success. Parkev also notes the company's forward P/E of 16.4 is attractive given the large total addressable market.

Mentioned Stocks

AFRM
Sentiment: BUYAction: RECOMMENDED

Reasoning: Parkev highlights Affirm's impressive 38% revenue CAGR since 2021 and its shift to a 21% operating profit margin. He notes that the business model is transparent and consumer-friendly, which builds trust and benefits both merchants and shoppers. Based on a forward P/E of 16.4 and an updated discounted cash flow (DCF) model, Parkev calculates a fair value of $88 per share, suggesting the stock is undervalued at its current $78 price point.

Loading chart...